[HTML][HTML] Diabetes and cardiovascular disease: epidemiology, biological mechanisms, treatment recommendations and future research

BM Leon, TM Maddox - World journal of diabetes, 2015 - ncbi.nlm.nih.gov
The incidence of diabetes mellitus (DM) continues to rise and has quickly become one of the
most prevalent and costly chronic diseases worldwide. A close link exists between DM and …

Metabolism and the circadian clock converge

K Eckel-Mahan, P Sassone-Corsi - Physiological reviews, 2013 - journals.physiology.org
Circadian rhythms occur in almost all species and control vital aspects of our physiology,
from sleeping and waking to neurotransmitter secretion and cellular metabolism …

Diabetes mellitus: a hypercoagulable state

ME Carr - Journal of Diabetes and its Complications, 2001 - Elsevier
Eighty percent of patients with diabetes mellitus die a thrombotic death. Seventy-five percent
of these deaths is due to cardiovascular complications, and the remainder is due to …

Plasminogen activator inhibitor‐1 (PAI‐1): a key factor linking fibrinolysis and age‐related subclinical and clinical conditions

M Cesari, M Pahor, RA Incalzi - Cardiovascular therapeutics, 2010 - Wiley Online Library
Introduction: The close relationship existing between aging and thrombosis has growingly
been studied in this last decade. The age‐related development of a prothrombotic …

A serpin with a finger in many PAIs: PAI-1's central function in thromboinflammation and cardiovascular disease

GB Morrow, CS Whyte, NJ Mutch - Frontiers in cardiovascular …, 2021 - frontiersin.org
Plasminogen activator inhibitor 1 (PAI-1) is a member of the serine protease inhibitor
(serpin) superfamily. PAI-1 is the principal inhibitor of the plasminogen activators, tissue …

Plasminogen-activator inhibitor type 1 and coronary artery disease

HP Kohler, PJ Grant - New England Journal of Medicine, 2000 - Mass Medical Soc
The development of coronary artery disease, and specifically myocardial infarction, involves
hyperplasia of arterial smooth muscle, the development of fatty streaks, atheroma formation …

[HTML][HTML] PAI‐1 and atherothrombosis

DE Vaughan - Journal of Thrombosis and Haemostasis, 2005 - Elsevier
Summary Plasminogen activator inhibitor‐1 (PAI‐1) is the major physiologic inhibitor of
tissue‐type plasminogen activator in plasma, and is elevated in a variety of clinical situations …

PAI-1 and the metabolic syndrome: links, causes, and consequences

MC Alessi, I Juhan-Vague - Arteriosclerosis, thrombosis, and …, 2006 - Am Heart Assoc
The link between plasminogen activator inhibitor (PAI)-1 and the metabolic syndrome with
obesity was established many years ago. Increased PAI-1 level can be now considered a …

Insulin resistance: cellular and clinical concepts

WT Cefalu - Experimental biology and medicine, 2001 - journals.sagepub.com
Insulin resistance is defined as a clinical state in which a normal or elevated insulin level
produces an attenuated biologic response. Specifically, the biologic response most studied …

Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease

DA Lane, PJ Grant - Blood, The Journal of the American Society …, 2000 - ashpublications.org
The development of thrombotic disorders in humans is one of the most common causes of
morbidity and mortality in the Western world. Thrombotic disease can be classified in broad …